BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 11840139)

  • 1. Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital.
    Grow WB; Moreb JS; Roque D; Manion K; Leather H; Reddy V; Khan SA; Finiewicz KJ; Nguyen H; Clancy CJ; Mehta PS; Wingard JR
    Bone Marrow Transplant; 2002 Jan; 29(1):15-9. PubMed ID: 11840139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive aspergillosis and allogeneic hematopoietic stem cell transplantation in children: a 15-year experience.
    Crassard N; Hadden H; Pondarré C; Hadden R; Galambrun C; Piens MA; Pracros JP; Souillet G; Basset T; Berthier JC; Philippe N; Bertrand Y
    Transpl Infect Dis; 2008 Jun; 10(3):177-83. PubMed ID: 18331389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for invasive aspergillosis in liver transplant recipients.
    Fortún J; Martín-Dávila P; Moreno S; De Vicente E; Nuño J; Candelas A; Bárcena R; García M
    Liver Transpl; 2002 Nov; 8(11):1065-70. PubMed ID: 12424722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and outcome of invasive Aspergillus infections in allogeneic BMT recipients.
    Jantunen E; Ruutu P; Piilonen A; Volin L; Parkkali T; Ruutu T
    Bone Marrow Transplant; 2000 Oct; 26(7):759-62. PubMed ID: 11042657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease.
    van Burik JA; Carter SL; Freifeld AG; High KP; Godder KT; Papanicolaou GA; Mendizabal AM; Wagner JE; Yanovich S; Kernan NA
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1487-98. PubMed ID: 18022579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-transplant infections: single center experience from the developing world.
    Ullah K; Raza S; Ahmed P; Chaudhry QU; Satti TM; Ahmed S; Mirza SH; Akhtar F; Kamal K; Akhtar FM
    Int J Infect Dis; 2008 Mar; 12(2):203-14. PubMed ID: 17920999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants.
    Ninin E; Milpied N; Moreau P; André-Richet B; Morineau N; Mahé B; Vigier M; Imbert BM; Morin O; Harousseau JL; Richet H
    Clin Infect Dis; 2001 Jul; 33(1):41-7. PubMed ID: 11389493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
    Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients.
    Mikulska M; Raiola AM; Bruno B; Furfaro E; Van Lint MT; Bregante S; Ibatici A; Del Bono V; Bacigalupo A; Viscoli C
    Bone Marrow Transplant; 2009 Sep; 44(6):361-70. PubMed ID: 19308042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years.
    Hovi L; Saarinen-Pihkala UM; Vettenranta K; Saxen H
    Bone Marrow Transplant; 2000 Nov; 26(9):999-1004. PubMed ID: 11100280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
    Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients.
    Konoplev S; Champlin RE; Giralt S; Ueno NT; Khouri I; Raad I; Rolston K; Jacobson K; Tarrand J; Luna M; Nguyen Q; Whimbey E
    Bone Marrow Transplant; 2001 Apr; 27(8):877-81. PubMed ID: 11477447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspergillus infections in bone marrow transplant recipients.
    Wingard JR; Beals SU; Santos GW; Merz WG; Saral R
    Bone Marrow Transplant; 1987 Aug; 2(2):175-81. PubMed ID: 3332165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive pulmonary aspergillosis following bone marrow transplantation: risk factors and diagnostic aspect.
    Soubani AO; Qureshi MA
    Haematologia (Budap); 2002; 32(4):427-37. PubMed ID: 12803117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance of cytomegalovirus infections in bone marrow transplant in Trieste: seven years' experience.
    D'Agaro P; Andolina M; Burgnich P; Samar E; Campello C
    Haematologica; 2000 Nov; 85(11 Suppl):54-7. PubMed ID: 11268325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients.
    Jantunen E; Piilonen A; Volin L; Parkkali T; Koukila-Kähkölä P; Ruutu T; Ruutu P
    Bone Marrow Transplant; 2000 Apr; 25(8):867-71. PubMed ID: 10808208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation.
    Romano V; Castagnola E; Dallorso S; Lanino E; Calvi A; Silvestro S; Morreale G; Giacchino R; Dini G
    Bone Marrow Transplant; 1999 Feb; 23(3):271-5. PubMed ID: 10084259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus infection after bone marrow transplantation in children.
    Castagnola E; Cappelli B; Erba D; Rabagliati A; Lanino E; Dini G
    Hum Immunol; 2004 May; 65(5):416-22. PubMed ID: 15172440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy.
    Lewis ID; DeFor T; Weisdorf DJ
    Bone Marrow Transplant; 2000 Sep; 26(5):539-43. PubMed ID: 11019844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation.
    Thursky K; Byrnes G; Grigg A; Szer J; Slavin M
    Bone Marrow Transplant; 2004 Jul; 34(2):115-21. PubMed ID: 15156166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.